Health Care & Life Sciences » Pharmaceuticals | Hisamitsu Pharmaceutical Co. Inc.

Hisamitsu Pharmaceutical Co. Inc. | Balance Sheet

Fiscal year is March-February. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
81,760
96,490
112,479
113,047
131,948
131,229
Total Accounts Receivable
36,837
46,252
37,355
35,772
34,946
39,662
Inventories
15,196
15,450
15,915
17,687
16,970
15,758
Other Current Assets
5,314
7,123
6,011
5,588
6,199
6,917
Total Current Assets
139,107
165,315
171,760
172,097
190,065
193,569
Net Property, Plant & Equipment
43,330
45,003
43,851
43,031
40,064
39,556
Total Investments and Advances
44,729
48,722
48,147
49,973
57,169
53,520
Intangible Assets
16,812
16,303
12,522
5,973
4,100
1,990
Other Assets
6,635
8,392
6,618
7,232
8,160
8,484
Total Assets
251,852
285,440
284,954
278,820
299,913
297,512
ST Debt & Current Portion LT Debt
1,789
1,787
1,716
1,583
1,490
Accounts Payable
8,987
17,851
14,016
14,380
13,911
Income Tax Payable
7,354
3,978
6,208
2,559
4,891
Other Current Liabilities
23,615
20,683
19,057
13,903
14,646
Total Current Liabilities
41,745
44,299
40,997
32,425
34,938
Long-Term Debt
1,008
790
689
608
568
Provision for Risks & Charges
6,465
7,210
6,821
7,028
7,297
Deferred Taxes
2,536
5,544
3,674
5,013
7,470
Other Liabilities
2,551
3,838
4,622
4,025
4,055
Total Liabilities
55,544
63,386
58,859
49,611
54,681
Common Equity (Total)
195,443
221,023
225,095
228,108
244,000
Total Shareholders' Equity
195,443
221,023
225,095
228,108
244,000
Total Equity
196,308
222,054
226,095
229,205
245,227
Liabilities & Shareholders' Equity
251,852
285,440
284,954
278,816
299,908
Accumulated Minority Interest
865
1,031
1,000
1,097
1,227

About Hisamitsu Pharmaceutical Co.

View Profile
Address
408 Tashiro Daikan-machi
Tosu Saga 841
Japan
Employees -
Website http://www.hisamitsu.co.jp
Updated 07/08/2019
Hisamitsu Pharmaceutical Co., Inc. engages in the research, development, manufacture, and sale of pharmaceuticals and related products. Its products are sold under Salonpas, Salonsip, Mohrus, ByeBye-Fever, Lifecella, and Keplat brands. It also provides ethical pharmaceuticals, over the counter drugs, medical devices, health supplements, and topical analgesic products.